Form 4 for APVO Aptevo Therapeutics Inc.
Accepted 2025-07-21 00:00:00 ET · period of report 2025-07-17 · accession 0000950170-25-097267 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-21 | 2025-07-17 | APVO | Lamothe Jeffrey G. | EVP, COO | M - OptEx | — | +5 | 6 | +500% | — |
| D | 2025-07-21 | 2025-07-17 | APVO | Lamothe Jeffrey G. | EVP, COO | M - OptEx | $0.00 | -5 | 12 | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (post-reverse split May ACTIVE) | 2025-07-17 | M | A | 5 | — | 6 | D | — | — | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Unit | 2025-07-17 | M | D | 5 | $0.00 | 12 | D | — · — to — | 17 Common Stock | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On July 17, 2024, the reporting person was granted 12,825 (17 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025. |